Return to Now:
Human DNA has now become a commodity, with 23andMe — the world’s largest database of genetic code — serving as the “new frontier” for pioneering drugmakers.
British pharmaceutical giant GlaxoSmithKline recently purchased a $300 million share in the genlogy company, which promises to tell you your ancestry in exchange for your DNA.
The “merger” of the two companies will accelerate the development of “novel treatments and cures,” GSK’s CEO wrote in a blog post.
Go to link